SCHEMBL2225797

SCHEMBL2225797

NS(=O)(=O)c1cccc(CNc2cc(Nc3ccc4c(c3)CCC4)ncn2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.44
ERBB3 P21860 1/20 0.44
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
GAA P10253 1/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA7 P43166 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CDK1 P06493 2/20 0.42
CCNB1 P14635 2/20 0.42
CCNA2 P20248 2/20 0.42
CCNE1 P24864 2/20 0.42
CDK2 P24941 2/20 0.42
CDK5 Q00535 2/20 0.42
CDK5R1 Q15078 2/20 0.42
JAK3 P52333 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2224438 0.81 TNNI3K (0.57) EGFRERBB3JAK3CCNT1CDK9
SCHEMBL2226138 0.81 TNNI3K (0.57) EGFRERBB3CDK1JAK3CA9
SCHEMBL2225416 0.81 NTRK1 (0.56) EGFRERBB3MAPTCDK2JAK3
SCHEMBL2225639 0.81 EGFR (0.44) EGFRERBB3ALDH1A1GAACDK1
SCHEMBL2226929 0.81 ALDH1A1 (0.48) EGFRERBB3KDM4EALDH1A1MAPT
SCHEMBL2224478 0.81 NTRK1 (0.47) EGFRERBB3CA1CDK1CCNB1
SCHEMBL2228327 0.81 CYP1A2 (0.52) EGFRERBB3KDM4EALDH1A1JAK3
SCHEMBL2225022 0.79 KDR (0.46) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2225667 0.79 JAK1 (0.47) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2225795 0.78 NTRK1 (0.46) EGFRERBB3CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed